Literature DB >> 32030209

Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma.

Huabin Li1, Shi Chen2, Lei Cheng3,4, Yinshi Guo5, He Lai6, Yong Li7, Xiaoping Lin8, Zheng Liu9, Qianhui Qiu10, Jie Shao11, Li Shi12, Man Tian13, Chengshuo Wang14, Hongtian Wang15,16, Xueyan Wang16, Qingyu Wei8, Yongxiang Wei17, Li Xiang18, Qintai Yang19, Changqing Zhao20, Huanping Zhang21, Yuxiang Zhi22, Junxiao Gao10, Quansheng Li8, Juan Liu1, Kuiji Wang14, Wencheng Zhou3,4, Luo Zhang14.   

Abstract

Entities:  

Year:  2019        PMID： 32030209      PMCID： PMC6988076          DOI： 10.21037/jtd.2019.12.37

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  72 in total

1.  Role of leptin in allergic rhinitis during sublingual immunotherapy.

Authors:  Yanhui Wen; Lifeng Zhou; Yuqiu Li; Zhengmin Li; Weijun Deng; Tao Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-14       Impact factor: 2.503

2.  Effect of sublingual immunotherapy on level of cytokines in PBMCs of patients with allergic asthma.

Authors:  Zhongxi Wang; Wenjing Li; Huan Chen; Wei Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

3.  SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.

Authors:  Holger Mosbech; G Walter Canonica; Vibeke Backer; Frederic de Blay; Ludger Klimek; Louise Broge; Christian Ljørring
Journal:  Ann Allergy Asthma Immunol       Date:  2015-02       Impact factor: 6.347

4.  [Evaluation of efficacy of 1 year after completing the 2-year specific sublingual immunotherapy treatment course in allergic rhinitis].

Authors:  L Han; Q J You; Z Li; H H Yang; H Fang; Y Zhang
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2017-07-07

Review 5.  Sublingual immunotherapy of house dust mite respiratory allergy in China.

Authors:  L Cheng; W-C Zhou
Journal:  Allergol Immunopathol (Madr)       Date:  2018-06-18       Impact factor: 1.667

Review 6.  The efficacy of sublingual immunotherapy for allergic diseases in Asia.

Authors:  Xuandao Liu; Chew Lip Ng; De Yun Wang
Journal:  Allergol Int       Date:  2018-03-16       Impact factor: 5.836

7.  Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school-age children with allergic rhinitis.

Authors:  L-X Tang; X-J Yang; P-P Wang; W-T Ge; J Zhang; Y-L Guo; J Lu; J Tai; Y-M Zhang; X Ni
Journal:  Allergol Immunopathol (Madr)       Date:  2018-01-11       Impact factor: 1.667

8.  EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

Authors:  G Roberts; O Pfaar; C A Akdis; I J Ansotegui; S R Durham; R Gerth van Wijk; S Halken; D Larenas-Linnemann; R Pawankar; C Pitsios; A Sheikh; M Worm; S Arasi; M A Calderon; C Cingi; S Dhami; J L Fauquert; E Hamelmann; P Hellings; L Jacobsen; E F Knol; S Y Lin; P Maggina; R Mösges; J N G Oude Elberink; G B Pajno; E A Pastorello; M Penagos; G Rotiroti; C B Schmidt-Weber; F Timmermans; O Tsilochristou; E-M Varga; J N Wilkinson; A Williams; L Zhang; I Agache; E Angier; M Fernandez-Rivas; M Jutel; S Lau; R van Ree; D Ryan; G J Sturm; A Muraro
Journal:  Allergy       Date:  2017-10-30       Impact factor: 13.146

9.  Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.

Authors:  O Pfaar; P Demoly; R Gerth van Wijk; S Bonini; J Bousquet; G W Canonica; S R Durham; L Jacobsen; H J Malling; R Mösges; N G Papadopoulos; S Rak; P Rodriguez del Rio; E Valovirta; U Wahn; M A Calderon
Journal:  Allergy       Date:  2014-04-25       Impact factor: 13.146

10.  Sublingual immunotherapy for treating adult patients with allergic rhinitis induced by house dust mite among Chinese Han population: A retrospective study.

Authors:  Miao Han; Yan Chen; Mi Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889
View more
  7 in total

1.  Morning Versus Evening Dosing of Sublingual Immunotherapy in Allergic Asthma: A Prospective Study.

Authors:  Feng Liao; Shi Chen; Ling Wang; Ying-Yu Quan; Li-Li Chen; Guo-Hua Lin
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

2.  Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis.

Authors:  Yandan Zhou; Min Xu; Wei Gong; Xiaoming Kang; Renzhong Guo; Jie Wen; Dinggang Zhou; Manjing Wang; Dazhi Shi; Qiancheng Jing
Journal:  Mediators Inflamm       Date:  2022-06-12       Impact factor: 4.529

3.  MicroRNA-375-mediated regulation of ILC2 cells through TSLP in allergic rhinitis.

Authors:  Xi Luo; Qingxiang Zeng; Shengbao Yan; Wenlong Liu; Renzhong Luo
Journal:  World Allergy Organ J       Date:  2020-08-09       Impact factor: 4.084

4.  Effects of sublingual-specific immunotherapy on pulmonary function and exhaled nitric oxide levels in asthmatic children with and without allergic rhinitis.

Authors:  Tao Ai; Li Wang; Ronghua Luo; Yinghong Fan; Huiling Liao; Wanmin Xia; Lei Zhang; Yaping Duan
Journal:  Transl Pediatr       Date:  2020-10

5.  Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite-Induced Allergic Rhinitis.

Authors:  Shaobing Xie; Hua Zhang; Fengjun Wang; Zhihai Xie; Weihong Jiang; Kelei Gao
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

6.  Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients.

Authors:  Kang Zhu; Cui Xia; Jingguo Chen; Chao Yu; Tianxi Gao; Jing Yan; Na Shao; Pin Zhu; Bin Sun; Xiaoyong Ren; Yanni Zhang
Journal:  Mediators Inflamm       Date:  2021-05-30       Impact factor: 4.711

7.  Multiple-Cytokine Profiling: A Novel Method for Early Prediction of the Efficacy of Sublingual Immunotherapy in Allergic Rhinitis Patients.

Authors:  Yanni Zhang; Kang Zhu; Cui Xia; Jingguo Chen; Chao Yu; Tianxi Gao; Jing Yan; Huihui Zhang; Xiaoyong Ren
Journal:  J Inflamm Res       Date:  2022-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.